Results 71 to 80 of about 11,690 (201)

Side effects and ineffectiveness of standard therapy for idiopathic recurrent pericarditis: status of the problem and description of clinical cases. Case report

open access: yesТерапевтический архив
Idiopathic recurrent pericarditis is a rare pathology characterised by recurrent inflammation in the cardiac cavity. Treatment of recurrent pericarditis is empirical and based on the use of drugs with anti-inflammatory properties.
Angelina A. Petrukhina   +6 more
doaj   +1 more source

Chronic Spontaneous Coronary Artery Dissection in a Young Woman Managed With Coronary Artery Bypass Grafting: A Case Report With Literature Review

open access: yesClinical Case Reports, Volume 14, Issue 7, July 2026.
ABSTRACT Spontaneous coronary artery dissection (SCAD) is an uncommon, non‐atherosclerotic cause of acute coronary syndrome, typically occurring in young to middle‐aged women. Although most cases resolve spontaneously with conservative therapy, a small proportion develop chronic dissections that require revascularization.
Gashaw Solela   +13 more
wiley   +1 more source

[Recurrent pericarditis as an initial manifestation of Wegener's granulomatosis.]

open access: yes, 2011
International audienceRecurrent pericarditis occur in around a quarter of patients after a first episode of acute pericarditis. Most of the cases are idiopathic or viral pericarditis or post-pericardial injury syndromes.
Seve, P.   +3 more
core   +1 more source

Pembrolizumab‐Associated Serositis With Recurrent Pleural Effusions Successfully Treated With Anakinra

open access: yesClinical Case Reports, Volume 14, Issue 7, July 2026.
ABSTRACT Immune checkpoint inhibitor–associated serositis is rare and may present with recurrent effusions. Some cases are steroid dependent, contributing to significant toxicity for patients. Guidance on steroid‐sparing therapy is limited. Our case describes IL‐1 blockade with anakinra which was well tolerated and effective, supporting its use as a ...
Emma McNally   +6 more
wiley   +1 more source

Pharmacologic treatment of acute and recurrent pericarditis. A systematic review and meta-analysis of controlled clinical trials

open access: yes, 2021
INTRODUCTION: Recurrence is the most frequent complication following acute pericarditis and may occur in 30% patients, rising to 50% in case of multiple recurrences, lack of colchicine treatment or use of glucocorticoids.
Biondi-Zoccai, Giuseppe   +4 more
core   +1 more source

Efficacy of an interleukin-1 beta receptor antagonist (Anakinra) in idiopathic recurrent pericarditis

open access: yes, 2013
Pericarditis may recur in up to 30 % of adult patients, but recurrent pericarditis is a rare disease in childhood. The etiology of the initial attack and the causes of recurrences often remain unknown.
Chiarelli F.   +3 more
core   +2 more sources

Ethanol Infusion Into the Vein of Marshall for Atrial Fibrillation: Clinical Efficacy and Technical Limitations

open access: yesClinical Cardiology, Volume 49, Issue 7, July 2026.
Evaluating EIVOM in atrial fibrillation: Clinical efficacy, mechanistic insights, and technical considerations. Abbreviations: AF, atrial fibrillation; AT, atrial tachycardia; CS, coronary sinus; EIVOM, ethanol infusion into the vein of Marshall; LAA, left atrial appendage; LIPV, left inferior pulmonary vein; MA, mitral annulus; MI, mitral isthmus; RF,
Xuepeng Zheng   +6 more
wiley   +1 more source

Failure of anti Interleukin-1 β monoclonal antibody in the treatment of recurrent pericarditis in two children

open access: yesPediatric Rheumatology Online Journal, 2020
Background Recurrent pericarditis (RP) is a complication (15–30%) of acute pericarditis with an unknown etiology. Treatment regimen consists of a combination of non-steroidal anti-inflammatory drugs (NSAIDs) and colchicine, with the addition of ...
Sara Signa   +12 more
doaj   +1 more source

The Role of Rilonacept in Recurrent Pericarditis [PDF]

open access: yesHeart International, 2021
Saberio Lo, Presti   +4 more
openaire   +2 more sources

The Multifaceted Role of Pyroptosis: Molecular Mechanisms, Crosstalk with Other Cell Death Pathways, and Therapeutic Implications

open access: yesMedComm, Volume 7, Issue 7, July 2026.
Pyroptosis maintains immune homeostasis by eliminating damaged or infected cells, but its dysregulation promotes inflammation and cancer progression. The diagram illustrates key activation pathways, links with other programmed cell deaths, and cancer‐specific effects, enhancing its dual protective and pathogenic roles.
Diego Liviu Boaru   +18 more
wiley   +1 more source

Home - About - Disclaimer - Privacy